MINNEAPOLIS, MN, USA, July 31, 2023/EINPresswire.com/ -- MLM Medical Labs (MLM), a premier Contract Research Organization (CRO) that provides comprehensive laboratory ...
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation. GenSciP166 was assayed in vitro as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results